Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

PPAR-γ signaling improves mitochondrial function in hair follicles, potentially affecting hair growth and aging.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Borderline newborn screening results should be carefully evaluated to prevent delayed diagnosis of thyroid issues.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

A balanced diet with essential micronutrients is crucial for healthy thyroid function.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

The VDR gene polymorphism does not affect BDNF levels in autoimmune thyroiditis and hypothyroidism patients.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

The document concludes that recent research has improved understanding of skin diseases and the balance between cell growth and differentiation in the epidermis.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Too much levothyroxine can cause hair loss in infants.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Retinoids might cause temporary hyperthyroidism in some patients.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.